JP2018077253A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018077253A5 JP2018077253A5 JP2018004851A JP2018004851A JP2018077253A5 JP 2018077253 A5 JP2018077253 A5 JP 2018077253A5 JP 2018004851 A JP2018004851 A JP 2018004851A JP 2018004851 A JP2018004851 A JP 2018004851A JP 2018077253 A5 JP2018077253 A5 JP 2018077253A5
- Authority
- JP
- Japan
- Prior art keywords
- mass spectrometry
- liquid chromatography
- amount
- ionization
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461992214P | 2014-05-12 | 2014-05-12 | |
| US61/992,214 | 2014-05-12 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016567654A Division JP6279104B2 (ja) | 2014-05-12 | 2015-05-12 | 質量分析によるタモキシフェンおよびその代謝産物の定量化 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021000689A Division JP2021073450A (ja) | 2014-05-12 | 2021-01-06 | 質量分析によるタモキシフェンおよびその代謝産物の定量化 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018077253A JP2018077253A (ja) | 2018-05-17 |
| JP2018077253A5 true JP2018077253A5 (enExample) | 2018-06-28 |
| JP6821610B2 JP6821610B2 (ja) | 2021-01-27 |
Family
ID=54367635
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016567654A Active JP6279104B2 (ja) | 2014-05-12 | 2015-05-12 | 質量分析によるタモキシフェンおよびその代謝産物の定量化 |
| JP2018004851A Active JP6821610B2 (ja) | 2014-05-12 | 2018-01-16 | 質量分析によるタモキシフェンおよびその代謝産物の定量化 |
| JP2021000689A Pending JP2021073450A (ja) | 2014-05-12 | 2021-01-06 | 質量分析によるタモキシフェンおよびその代謝産物の定量化 |
| JP2023080724A Pending JP2023109874A (ja) | 2014-05-12 | 2023-05-16 | 質量分析によるタモキシフェンおよびその代謝産物の定量化 |
| JP2025018885A Active JP7884626B2 (ja) | 2014-05-12 | 2025-02-07 | 質量分析によるタモキシフェンおよびその代謝産物の定量化 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016567654A Active JP6279104B2 (ja) | 2014-05-12 | 2015-05-12 | 質量分析によるタモキシフェンおよびその代謝産物の定量化 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021000689A Pending JP2021073450A (ja) | 2014-05-12 | 2021-01-06 | 質量分析によるタモキシフェンおよびその代謝産物の定量化 |
| JP2023080724A Pending JP2023109874A (ja) | 2014-05-12 | 2023-05-16 | 質量分析によるタモキシフェンおよびその代謝産物の定量化 |
| JP2025018885A Active JP7884626B2 (ja) | 2014-05-12 | 2025-02-07 | 質量分析によるタモキシフェンおよびその代謝産物の定量化 |
Country Status (9)
| Country | Link |
|---|---|
| US (7) | US9459267B2 (enExample) |
| EP (2) | EP3143392B1 (enExample) |
| JP (5) | JP6279104B2 (enExample) |
| CN (2) | CN110044998B (enExample) |
| AU (6) | AU2015259294A1 (enExample) |
| BR (1) | BR112016026459B1 (enExample) |
| CA (1) | CA2948823C (enExample) |
| SA (1) | SA516380291B1 (enExample) |
| WO (1) | WO2015175561A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4718073A3 (en) * | 2008-12-24 | 2026-07-29 | Quest Diagnostics Investments LLC | Mass spectrometry assay for congenital adrenal hyperplasia |
| CN110044998B (zh) * | 2014-05-12 | 2021-12-14 | 奎斯特诊断投资公司 | 通过质谱法定量他莫昔芬及其代谢物 |
| CN105159539B (zh) * | 2015-09-10 | 2018-06-01 | 京东方科技集团股份有限公司 | 可穿戴设备的触控响应方法、装置及可穿戴设备 |
| CA3153535A1 (en) | 2019-10-10 | 2021-04-15 | Rachel MULLEN | Liquid chromatography-mass spectrometry (lc-ms) methods for analyzing ampholyte lot variation |
| EP4097256A1 (en) | 2020-01-31 | 2022-12-07 | Regeneron Pharmaceuticals, Inc. | Use of liquid chromatography and mass spectrometry to characterize oligonucleotides |
| US12105102B2 (en) | 2022-03-30 | 2024-10-01 | University Of Utah Research Foundation | Methods for quantifying insulin-like growth factor-1 and insulin-like growth factor-2 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5119827A (en) * | 1990-09-05 | 1992-06-09 | Board Of Regents, The University Of Texas System | Mechanisms of antiestrogen resistance in breast cancer |
| US5605798A (en) | 1993-01-07 | 1997-02-25 | Sequenom, Inc. | DNA diagnostic based on mass spectrometry |
| PT700521E (pt) | 1993-05-28 | 2003-10-31 | Baylor College Medicine | Metodo e espectrometro de massa para dessorcao e ionizacao de analitos |
| IES950928A2 (en) * | 1995-12-08 | 1996-02-21 | Bunskellig Limited | "A process for analysing a fluid" |
| GB9717926D0 (en) | 1997-08-22 | 1997-10-29 | Micromass Ltd | Methods and apparatus for tandem mass spectrometry |
| JP2002502086A (ja) | 1998-01-23 | 2002-01-22 | アナリティカ オブ ブランフォード インコーポレーテッド | 表面からの質量分光測定 |
| CN1871517A (zh) * | 2002-02-19 | 2006-11-29 | 免疫公司 | 快速有效分离循环癌细胞的方法和试剂 |
| EP2050443B1 (en) * | 2002-12-18 | 2017-05-24 | Besins Healthcare Luxembourg SARL | Reduction of breast density with 4-hydroxy tamoxifen |
| CA2519980C (en) | 2003-04-01 | 2012-04-10 | Laboratoires Besins International | Prevention and treatment of breast cancer with 4-hydroxy tamoxifen |
| WO2005064344A1 (ja) * | 2003-12-26 | 2005-07-14 | Takeda Pharmaceutical Company Limited | 脂質代謝異常症の予測方法 |
| MY145634A (en) * | 2003-12-29 | 2012-03-15 | Bristol Myers Squibb Co | Pyrrolotriazine compounds as kinase inhibitors |
| US20060105045A1 (en) * | 2004-11-08 | 2006-05-18 | Buchanan Charles M | Cyclodextrin solubilizers for liquid and semi-solid formulations |
| US20090291134A1 (en) * | 2006-11-21 | 2009-11-26 | Jina Pharmaceuticals, Inc. | Endoxifen methods and compositions in the treatment of psychiatric and neurodegenerative diseases |
| US8017403B2 (en) * | 2007-06-14 | 2011-09-13 | Quest Diagnostics Investments Incorporated | Mass spectrometry method for measuring vitamin B6 in body fluid |
| US20090134325A1 (en) * | 2007-11-27 | 2009-05-28 | Goldman Mildred M | Methods for detecting estradiol by mass spectrometry |
| US8916385B2 (en) * | 2007-12-13 | 2014-12-23 | Quest Diagnostics Investments, Inc. | Methods for detecting estrone by mass spectrometry |
| US7834313B2 (en) | 2008-08-08 | 2010-11-16 | Quest Diagnostics Investments Incorporated | Mass spectrometry assay for plasma-renin |
| IL313131A (en) * | 2009-02-11 | 2024-07-01 | Caris Mpi Inc | Molecular characterization of tumors |
| US20110081675A1 (en) * | 2009-10-06 | 2011-04-07 | Wisconsin Alumni Research Foundation | Metabolic Biomarkers Of Drug-Induced Cardiotoxicity |
| WO2012119010A2 (en) * | 2011-03-01 | 2012-09-07 | Indiana University Research And Technology Corporation | Materials for inhibiting aromatase and method of using the same to diagnose, treat and monitor breast cancer |
| WO2012167126A1 (en) | 2011-06-03 | 2012-12-06 | Purdue Research Foundation | Ion generation using modified wetted porous materials |
| WO2013134230A1 (en) * | 2012-03-05 | 2013-09-12 | Xavier University | Boron-based 4-hydroxytamoxifen and endoxifen prodrugs as treatment for breast cancer |
| JP6216786B2 (ja) * | 2012-07-17 | 2017-10-18 | ソウル大学校産学協力団Ｓｎｕ Ｒ＆Ｄｂ Ｆｏｕｎｄａｔｉｏｎ | 質量スペクトルの再現性向上方法およびこれを用いた定量分析方法 |
| CN103494787B (zh) * | 2013-07-22 | 2014-10-29 | 南通广泰生化制品有限公司 | 枸橼酸他莫昔芬滴丸 |
| CN110044998B (zh) * | 2014-05-12 | 2021-12-14 | 奎斯特诊断投资公司 | 通过质谱法定量他莫昔芬及其代谢物 |
-
2015
- 2015-05-12 CN CN201910220665.6A patent/CN110044998B/zh active Active
- 2015-05-12 EP EP15793289.8A patent/EP3143392B1/en active Active
- 2015-05-12 EP EP23157017.7A patent/EP4220178A3/en active Pending
- 2015-05-12 AU AU2015259294A patent/AU2015259294A1/en not_active Abandoned
- 2015-05-12 US US14/710,311 patent/US9459267B2/en active Active
- 2015-05-12 CA CA2948823A patent/CA2948823C/en active Active
- 2015-05-12 WO PCT/US2015/030419 patent/WO2015175561A1/en not_active Ceased
- 2015-05-12 BR BR112016026459-2A patent/BR112016026459B1/pt active IP Right Grant
- 2015-05-12 CN CN201580037630.9A patent/CN106537139B/zh active Active
- 2015-05-12 JP JP2016567654A patent/JP6279104B2/ja active Active
-
2016
- 2016-10-03 US US15/284,248 patent/US9835606B2/en active Active
- 2016-11-13 SA SA516380291A patent/SA516380291B1/ar unknown
-
2017
- 2017-12-04 US US15/830,812 patent/US10830746B2/en active Active
-
2018
- 2018-01-16 JP JP2018004851A patent/JP6821610B2/ja active Active
- 2018-12-07 AU AU2018275011A patent/AU2018275011A1/en not_active Abandoned
-
2020
- 2020-09-23 AU AU2020239700A patent/AU2020239700B2/en active Active
- 2020-11-09 US US17/093,472 patent/US11428682B2/en active Active
-
2021
- 2021-01-06 JP JP2021000689A patent/JP2021073450A/ja active Pending
-
2022
- 2022-04-20 AU AU2022202628A patent/AU2022202628B2/en active Active
- 2022-08-23 US US17/893,950 patent/US11835505B2/en active Active
-
2023
- 2023-05-16 JP JP2023080724A patent/JP2023109874A/ja active Pending
- 2023-07-07 AU AU2023204389A patent/AU2023204389B2/en active Active
- 2023-10-25 US US18/494,030 patent/US12270803B2/en active Active
-
2024
- 2024-10-09 AU AU2024227191A patent/AU2024227191B2/en active Active
-
2025
- 2025-02-07 JP JP2025018885A patent/JP7884626B2/ja active Active
- 2025-03-07 US US19/074,121 patent/US20260118337A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Berg et al. | 13C labelled internal standards—A solution to minimize ion suppression effects in liquid chromatography–tandem mass spectrometry analyses of drugs in biological samples? | |
| Gould et al. | Breath analysis for detection of viral infection, the current position of the field | |
| JP2017516104A5 (enExample) | ||
| Helm et al. | Ion mobility tandem mass spectrometry enhances performance of bottom-up proteomics | |
| JP2011504596A5 (enExample) | ||
| JP2011505013A5 (enExample) | ||
| JP2011530701A5 (enExample) | ||
| JP2013513802A5 (enExample) | ||
| Fukuyama et al. | Alkylated dihydroxybenzoic acid as a MALDI matrix additive for hydrophobic peptide analysis | |
| EP3570315A3 (en) | Rapid evaporative ionisation mass spectrometry ("reims") and desorption electrospray ionisation mass spectrometry ("desi-ms") analysis of biopsy samples | |
| WO2006130474A3 (en) | Multi-beam ion mobility time-of-flight mass spectrometer with bipolar ion extraction and zwitterion detection | |
| WO2009140849A1 (zh) | 双面离子源 | |
| Chingin et al. | Rapid recognition of bacteremia in humans using atmospheric pressure chemical ionization mass spectrometry of volatiles emitted by blood cultures | |
| JP2020507883A5 (enExample) | ||
| Wong et al. | Advances in rapid detection of SARS-CoV-2 by mass spectrometry | |
| SA516380291B1 (ar) | الحساب الكمي لتاموكسيفين ونواتج أيضه بواسطة القياس الطيفي الكتلي | |
| Liu et al. | Matrix effects in the liquid chromatography-tandem mass spectrometry method of analysis | |
| RU2018104707A (ru) | ИСПОЛЬЗОВАНИЕ МОЛЕКУЛЯРНЫХ МАРКЕРОВ IL-3, IL-33 и IL12ρ40 ДЛЯ ХАРАКТЕРИСТИКИ СТЕПЕНИ ТЯЖЕСТИ РЕСПИРАТОРНЫХ ИНФЕКЦИЙ, ВЫЗВАННЫХ РЕСПИРАТОРНО-СИНЦИТИАЛЬНЫМ ВИРУСОМ ЧЕЛОВЕКА И МЕТАПНЕВМОВИРУСОМ ЧЕЛОВЕКА | |
| Kailasa et al. | Electrospray ionization tandem mass spectrometry for rapid, sensitive and direct detection of melamine in dairy products | |
| JP2024515443A5 (enExample) | ||
| Rincón et al. | Evaluation of peripheral blood microsampling techniques in combination with liquid chromatography‐high resolution mass spectrometry for the determination of drug pharmacokinetics in clinical studies | |
| BR112022004390A2 (pt) | Métodos de lc-ms para isotipagem e quantificação de anticorpos | |
| Qi-Sheng et al. | Analysis of ISG15-modified proteins from A549 cells in response to influenza virus infection by liquid chromatography-tandem mass spectrometry | |
| Schreiber et al. | LC-MS/MS analysis of emerging food contaminants | |
| RU2015104248A (ru) | Способ идентификации органических соединений методом хроматр-масс-спектрометрии |